Bausch Health Companies Inc. (TSX:BHC)

Canada · Delayed Price · Currency is CAD

9.61

-0.71 (-6.88%)

At close: Dec 5, 2025

-16.00% (1Y)

Market Cap	3.81B
Revenue (ttm)	13.97B
Net Income (ttm)	504.23M
Shares Out	n/a
EPS (ttm)	1.35
PE Ratio	7.56
Forward PE	1.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	494,214
Average Volume	417,202
Open	10.37
Previous Close	10.32
Day's Range	9.59 - 10.37
52-Week Range	5.91 - 12.07
Beta	0.40
RSI	55.25
Earnings Date	Feb 19, 2026

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

CEO Thomas Appio

Employees 20,700

Stock Exchange Toronto Stock Exchange

Ticker Symbol BHC

Full Company Profile

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD Financial Statements

News

John Paulson's Strategic Acquisition in Bausch Health Companies Inc.

2 days ago - GuruFocus

Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript

3 days ago - Seeking Alpha

Why Bausch Health Companies Stock Rocketed 11% Higher Today

Investors were obviously impressed with the company's latest acquisition.

4 days ago - The Motley Fool

Biggest Stock Movers Today, Dec. 1: BHC, SMR, & More

Major stock market indexes were down on Monday but closed well above their worst levels of the day. A healthcare stock was one of the best performers on the day.

4 days ago - The Motley Fool

Bausch Health (BHC) Shares Surge by Nearly 15%

4 days ago - GuruFocus

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Leggett & Platt Inc (NYSE: LEG) rose sharply during Monday's session r after it received a proposal from Somn...

4 days ago - Benzinga

Why Are Shares Of Bausch Health Up Today?

Shares of Bausch Health Companies Inc. (NASDAQ: BHC) are trading higher Monday after the company announced it acquired a technology firm through one of its subsidiaries . BHC stock is racing ahead of...

4 days ago - Benzinga

Bausch Health (BHC) Shares Surge Over 11% Amid Market Gains

4 days ago - GuruFocus

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Transaction boosts Solta Medical's position to meet rising demand in China's growing aesthetics market LAVAL, QC / ACCESS Newswire / December 1, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...

4 days ago - Accesswire

Do Options Traders Know Something About Bausch Health Stock We Don't?

Investors need to pay close attention to BHC stock based on the movements in the options market lately.

10 days ago - Nasdaq

Bausch Health (BHC) Initiates Exchange Offer for Debt Management

11 days ago - GuruFocus

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced the commencement of offers to exchange the Company...

11 days ago - Accesswire

Bausch (BHC) Upgraded to Buy: Here's Why

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

16 days ago - Nasdaq

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, wil...

17 days ago - Accesswire

John Paulson's hedge fund boosts Bausch Health, trims Madrigal in Q3 moves

21 days ago - Seeking Alpha

John Paulson's Strategic Move: Significant Increase in Bausch Health Companies Inc.

21 days ago - GuruFocus

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical

Bausch + Lomb CEO Brent Saunders joins 'Squawk Box' to preview the company's investor day, details of the company's three-year plan for profitable growth, impact of tariffs, and more.

22 days ago - CNBC Television